IOL

Lens fragmentation device may avoid disrupting zonules, enhance refractive outcomes

Scleral suturing of a dislocated IOL and exchange of the original lens with an iris-claw IOL were comparable for achieving good visual outcomes with low complication rates.

Dexamethasone intraocular suspension 9% is similar to topical prednisolone acetate, giving physicians another choice when tackling IOP in patients.

Patients report improved intermediate vision, quality distance sight after surgery

Low to moderate myopes are among the most challenging patients to satisfy with cataract surgery

Annual survey from ASCRS/ESCRS pinpoints trends in explantation

A diffractive trifocal IOL achieved satisfactory vision with a high rate of spectacle independence

Pearls can ensure physicians get best outcomes, help patients set realistic goals

ICYMI: Dr. Packer shares the pearls from his 2019 ASCRS presentation 

ICYMI: Frank W. Bowden, III, MD, FACS shares the take-home message from his 2019 ASCRS presentation. Check it out below!

Eva Liang, MD, discusses the take-home message from her presentation at ASCRS 2019

Dr Jacqueline Beltz, FRANZCO, shares the take-home message from her 2019 ASCRS presentation

Demographic shifts, improving technology continue to bring patients in at younger age

EDOF, multifocal IOLs providing options for patients with range of visual needs

Retina specialist Ron M. Kurtz, MD, details the way collaborative innovation can improve the lives of ophthalmic surgeons, and their patients.

New technology offers surgeons the unfolding efficiency of an enhanced material along with the rotational stability that characterizes the current toric platform.